Drug-Induced Urinary Incontinence
Physiological urinary continence depends on many factors that are potentially vulnerable to adverse drug effects, which may lead to incontinence. In principle, drugs could cause incontinence by lowering bladder outlet resistance and/or by increasing intravesical pressure, which disrupts the normal p...
Gespeichert in:
Veröffentlicht in: | Drugs & aging 2008-01, Vol.25 (7), p.541-549 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 549 |
---|---|
container_issue | 7 |
container_start_page | 541 |
container_title | Drugs & aging |
container_volume | 25 |
creator | Tsakiris, Peter Oelke, Matthias Michel, Martin C. |
description | Physiological urinary continence depends on many factors that are potentially vulnerable to adverse drug effects, which may lead to incontinence. In principle, drugs could cause incontinence by lowering bladder outlet resistance and/or by increasing intravesical pressure, which disrupts the normal pressure relationship between the bladder and urethra and leads to urinary leakage; other possibilities include disturbances of central nervous control of voiding or an overproduction of urine. While many drug groups could theoretically induce urinary incontinence based upon pathophysiological considerations, evidence demonstrating a cause-effect relationship between drug usage and incontinence is sparse. Drug classes in which induction of incontinence has been proposed include α
1
-adrenoceptor antagonists, antipsychotics, benzodiazepines, antidepressants and hormone replacement therapy in postmenopausal women. However, other drug classes are not innocent in terms of causing urinary incontinence and physicians are well advised to closely monitor patients for the occurrence of incontinence after new prescriptions and/or major dosage changes. |
doi_str_mv | 10.2165/00002512-200825070-00001 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_223084907</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A200671102</galeid><sourcerecordid>A200671102</sourcerecordid><originalsourceid>FETCH-LOGICAL-c487t-a3a4d37916533fc0a22e531e800a9e07b9018985c1c58e9c320f6bcb41773f633</originalsourceid><addsrcrecordid>eNqFkE1LAzEQhoMoflT_glTF49aZye4mOYqfhYIXBW8hzWbLljZbk-7Bf2_sVkUQTA4Jk-edvPMyNkQYEZbFFaRFBVJGAJIKEJB9lnCHHSIKlaEq1e7mDhmRej1gRzHOE1ES4T47QFlIwpwfsrPb0M2ysa8666rhS2i8Ce_DsbetXzfeeeuO2V5tFtGdbM8Be7m_e755zCZPD-Ob60lmcynWmeEmr7hQyR7ntQVD5AqOTgIY5UBMFaBUsrBoC-mU5QR1ObXTHIXgdcn5gJ33fVehfetcXOt52wWfvtREHGSuQCTooodmZuF04-t2HYxdNtHq65RFKRCBEjX6g0q7cssmTebqJtV_CWQvsKGNMbhar0KzTEloBP2ZuP5KXH8nvilhkp5ubXfTpat-hNuIE3C5BUy0ZlEH420TvzmCAkvMZeJUz8X05Gcu_Mz_r4kP85aT8A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>223084907</pqid></control><display><type>article</type><title>Drug-Induced Urinary Incontinence</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Tsakiris, Peter ; Oelke, Matthias ; Michel, Martin C.</creator><creatorcontrib>Tsakiris, Peter ; Oelke, Matthias ; Michel, Martin C.</creatorcontrib><description>Physiological urinary continence depends on many factors that are potentially vulnerable to adverse drug effects, which may lead to incontinence. In principle, drugs could cause incontinence by lowering bladder outlet resistance and/or by increasing intravesical pressure, which disrupts the normal pressure relationship between the bladder and urethra and leads to urinary leakage; other possibilities include disturbances of central nervous control of voiding or an overproduction of urine. While many drug groups could theoretically induce urinary incontinence based upon pathophysiological considerations, evidence demonstrating a cause-effect relationship between drug usage and incontinence is sparse. Drug classes in which induction of incontinence has been proposed include α
1
-adrenoceptor antagonists, antipsychotics, benzodiazepines, antidepressants and hormone replacement therapy in postmenopausal women. However, other drug classes are not innocent in terms of causing urinary incontinence and physicians are well advised to closely monitor patients for the occurrence of incontinence after new prescriptions and/or major dosage changes.</description><identifier>ISSN: 1170-229X</identifier><identifier>EISSN: 1179-1969</identifier><identifier>DOI: 10.2165/00002512-200825070-00001</identifier><identifier>PMID: 18582143</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Adrenergic Antagonists - adverse effects ; Adrenergic receptors ; Antidepressive Agents - adverse effects ; Antipsychotic Agents - adverse effects ; Benzodiazepines - adverse effects ; Biological and medical sciences ; Bladder ; Diuretics - adverse effects ; Drug toxicity and drugs side effects treatment ; Drugs ; Estrogen Replacement Therapy - adverse effects ; Geriatrics/Gerontology ; Hormone replacement therapy ; Humans ; Iatrogenesis ; Internal Medicine ; Leading Article ; Medical sciences ; Medicine ; Medicine & Public Health ; Nephrology. Urinary tract diseases ; Pharmacology. Drug treatments ; Pharmacology/Toxicology ; Pharmacotherapy ; Physiology ; Practice Guidelines as Topic ; Risk Assessment ; Smooth muscle ; Toxicity: urogenital system ; Urinary Bladder - drug effects ; Urinary Bladder - physiopathology ; Urinary incontinence ; Urinary Incontinence - chemically induced ; Urinary Incontinence - physiopathology ; Urinary system involvement in other diseases. Miscellaneous ; Urinary tract. Prostate gland ; Urine ; Urogenital system</subject><ispartof>Drugs & aging, 2008-01, Vol.25 (7), p.541-549</ispartof><rights>Adis Data Information BV 2008</rights><rights>2008 INIST-CNRS</rights><rights>COPYRIGHT 2008 Wolters Kluwer Health, Inc.</rights><rights>Copyright Wolters Kluwer Health Adis International 2008</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c487t-a3a4d37916533fc0a22e531e800a9e07b9018985c1c58e9c320f6bcb41773f633</citedby><cites>FETCH-LOGICAL-c487t-a3a4d37916533fc0a22e531e800a9e07b9018985c1c58e9c320f6bcb41773f633</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.2165/00002512-200825070-00001$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.2165/00002512-200825070-00001$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20516148$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18582143$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tsakiris, Peter</creatorcontrib><creatorcontrib>Oelke, Matthias</creatorcontrib><creatorcontrib>Michel, Martin C.</creatorcontrib><title>Drug-Induced Urinary Incontinence</title><title>Drugs & aging</title><addtitle>Drugs Aging</addtitle><addtitle>Drugs Aging</addtitle><description>Physiological urinary continence depends on many factors that are potentially vulnerable to adverse drug effects, which may lead to incontinence. In principle, drugs could cause incontinence by lowering bladder outlet resistance and/or by increasing intravesical pressure, which disrupts the normal pressure relationship between the bladder and urethra and leads to urinary leakage; other possibilities include disturbances of central nervous control of voiding or an overproduction of urine. While many drug groups could theoretically induce urinary incontinence based upon pathophysiological considerations, evidence demonstrating a cause-effect relationship between drug usage and incontinence is sparse. Drug classes in which induction of incontinence has been proposed include α
1
-adrenoceptor antagonists, antipsychotics, benzodiazepines, antidepressants and hormone replacement therapy in postmenopausal women. However, other drug classes are not innocent in terms of causing urinary incontinence and physicians are well advised to closely monitor patients for the occurrence of incontinence after new prescriptions and/or major dosage changes.</description><subject>Adrenergic Antagonists - adverse effects</subject><subject>Adrenergic receptors</subject><subject>Antidepressive Agents - adverse effects</subject><subject>Antipsychotic Agents - adverse effects</subject><subject>Benzodiazepines - adverse effects</subject><subject>Biological and medical sciences</subject><subject>Bladder</subject><subject>Diuretics - adverse effects</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Drugs</subject><subject>Estrogen Replacement Therapy - adverse effects</subject><subject>Geriatrics/Gerontology</subject><subject>Hormone replacement therapy</subject><subject>Humans</subject><subject>Iatrogenesis</subject><subject>Internal Medicine</subject><subject>Leading Article</subject><subject>Medical sciences</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Pharmacology. Drug treatments</subject><subject>Pharmacology/Toxicology</subject><subject>Pharmacotherapy</subject><subject>Physiology</subject><subject>Practice Guidelines as Topic</subject><subject>Risk Assessment</subject><subject>Smooth muscle</subject><subject>Toxicity: urogenital system</subject><subject>Urinary Bladder - drug effects</subject><subject>Urinary Bladder - physiopathology</subject><subject>Urinary incontinence</subject><subject>Urinary Incontinence - chemically induced</subject><subject>Urinary Incontinence - physiopathology</subject><subject>Urinary system involvement in other diseases. Miscellaneous</subject><subject>Urinary tract. Prostate gland</subject><subject>Urine</subject><subject>Urogenital system</subject><issn>1170-229X</issn><issn>1179-1969</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqFkE1LAzEQhoMoflT_glTF49aZye4mOYqfhYIXBW8hzWbLljZbk-7Bf2_sVkUQTA4Jk-edvPMyNkQYEZbFFaRFBVJGAJIKEJB9lnCHHSIKlaEq1e7mDhmRej1gRzHOE1ES4T47QFlIwpwfsrPb0M2ysa8666rhS2i8Ce_DsbetXzfeeeuO2V5tFtGdbM8Be7m_e755zCZPD-Ob60lmcynWmeEmr7hQyR7ntQVD5AqOTgIY5UBMFaBUsrBoC-mU5QR1ObXTHIXgdcn5gJ33fVehfetcXOt52wWfvtREHGSuQCTooodmZuF04-t2HYxdNtHq65RFKRCBEjX6g0q7cssmTebqJtV_CWQvsKGNMbhar0KzTEloBP2ZuP5KXH8nvilhkp5ubXfTpat-hNuIE3C5BUy0ZlEH420TvzmCAkvMZeJUz8X05Gcu_Mz_r4kP85aT8A</recordid><startdate>20080101</startdate><enddate>20080101</enddate><creator>Tsakiris, Peter</creator><creator>Oelke, Matthias</creator><creator>Michel, Martin C.</creator><general>Springer International Publishing</general><general>Adis International</general><general>Wolters Kluwer Health, Inc</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4T-</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope></search><sort><creationdate>20080101</creationdate><title>Drug-Induced Urinary Incontinence</title><author>Tsakiris, Peter ; Oelke, Matthias ; Michel, Martin C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c487t-a3a4d37916533fc0a22e531e800a9e07b9018985c1c58e9c320f6bcb41773f633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adrenergic Antagonists - adverse effects</topic><topic>Adrenergic receptors</topic><topic>Antidepressive Agents - adverse effects</topic><topic>Antipsychotic Agents - adverse effects</topic><topic>Benzodiazepines - adverse effects</topic><topic>Biological and medical sciences</topic><topic>Bladder</topic><topic>Diuretics - adverse effects</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Drugs</topic><topic>Estrogen Replacement Therapy - adverse effects</topic><topic>Geriatrics/Gerontology</topic><topic>Hormone replacement therapy</topic><topic>Humans</topic><topic>Iatrogenesis</topic><topic>Internal Medicine</topic><topic>Leading Article</topic><topic>Medical sciences</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Pharmacology. Drug treatments</topic><topic>Pharmacology/Toxicology</topic><topic>Pharmacotherapy</topic><topic>Physiology</topic><topic>Practice Guidelines as Topic</topic><topic>Risk Assessment</topic><topic>Smooth muscle</topic><topic>Toxicity: urogenital system</topic><topic>Urinary Bladder - drug effects</topic><topic>Urinary Bladder - physiopathology</topic><topic>Urinary incontinence</topic><topic>Urinary Incontinence - chemically induced</topic><topic>Urinary Incontinence - physiopathology</topic><topic>Urinary system involvement in other diseases. Miscellaneous</topic><topic>Urinary tract. Prostate gland</topic><topic>Urine</topic><topic>Urogenital system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tsakiris, Peter</creatorcontrib><creatorcontrib>Oelke, Matthias</creatorcontrib><creatorcontrib>Michel, Martin C.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><jtitle>Drugs & aging</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tsakiris, Peter</au><au>Oelke, Matthias</au><au>Michel, Martin C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Drug-Induced Urinary Incontinence</atitle><jtitle>Drugs & aging</jtitle><stitle>Drugs Aging</stitle><addtitle>Drugs Aging</addtitle><date>2008-01-01</date><risdate>2008</risdate><volume>25</volume><issue>7</issue><spage>541</spage><epage>549</epage><pages>541-549</pages><issn>1170-229X</issn><eissn>1179-1969</eissn><abstract>Physiological urinary continence depends on many factors that are potentially vulnerable to adverse drug effects, which may lead to incontinence. In principle, drugs could cause incontinence by lowering bladder outlet resistance and/or by increasing intravesical pressure, which disrupts the normal pressure relationship between the bladder and urethra and leads to urinary leakage; other possibilities include disturbances of central nervous control of voiding or an overproduction of urine. While many drug groups could theoretically induce urinary incontinence based upon pathophysiological considerations, evidence demonstrating a cause-effect relationship between drug usage and incontinence is sparse. Drug classes in which induction of incontinence has been proposed include α
1
-adrenoceptor antagonists, antipsychotics, benzodiazepines, antidepressants and hormone replacement therapy in postmenopausal women. However, other drug classes are not innocent in terms of causing urinary incontinence and physicians are well advised to closely monitor patients for the occurrence of incontinence after new prescriptions and/or major dosage changes.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>18582143</pmid><doi>10.2165/00002512-200825070-00001</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1170-229X |
ispartof | Drugs & aging, 2008-01, Vol.25 (7), p.541-549 |
issn | 1170-229X 1179-1969 |
language | eng |
recordid | cdi_proquest_journals_223084907 |
source | MEDLINE; SpringerNature Journals |
subjects | Adrenergic Antagonists - adverse effects Adrenergic receptors Antidepressive Agents - adverse effects Antipsychotic Agents - adverse effects Benzodiazepines - adverse effects Biological and medical sciences Bladder Diuretics - adverse effects Drug toxicity and drugs side effects treatment Drugs Estrogen Replacement Therapy - adverse effects Geriatrics/Gerontology Hormone replacement therapy Humans Iatrogenesis Internal Medicine Leading Article Medical sciences Medicine Medicine & Public Health Nephrology. Urinary tract diseases Pharmacology. Drug treatments Pharmacology/Toxicology Pharmacotherapy Physiology Practice Guidelines as Topic Risk Assessment Smooth muscle Toxicity: urogenital system Urinary Bladder - drug effects Urinary Bladder - physiopathology Urinary incontinence Urinary Incontinence - chemically induced Urinary Incontinence - physiopathology Urinary system involvement in other diseases. Miscellaneous Urinary tract. Prostate gland Urine Urogenital system |
title | Drug-Induced Urinary Incontinence |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T16%3A05%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Drug-Induced%20Urinary%20Incontinence&rft.jtitle=Drugs%20&%20aging&rft.au=Tsakiris,%20Peter&rft.date=2008-01-01&rft.volume=25&rft.issue=7&rft.spage=541&rft.epage=549&rft.pages=541-549&rft.issn=1170-229X&rft.eissn=1179-1969&rft_id=info:doi/10.2165/00002512-200825070-00001&rft_dat=%3Cgale_proqu%3EA200671102%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=223084907&rft_id=info:pmid/18582143&rft_galeid=A200671102&rfr_iscdi=true |